Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Jun 27, 2022 8:19pm

336 Views

Post# 34786124

Among most accessed between 06/2021 to 05/2022 too

Not only did we only benefited of only 11 months of visibility during the Jan. 1, 2019 to December 31, 2020 given our article was published despite on February 05. 2020:

Theralase® Research – One of the Top 10 Most Downloaded Papers - Between January 1, 2019 to December 31, 2020

... but we are also still among the most accessed between 06/2021 to 05/2022, despite being a February 05, 2020 article. See last link at the bottom of this page: